Company SMEDI Co., Ltd.

Company SMEDI Co., Ltd.

A118000

KR7118000009

Pharmaceuticals

Equities

A118000

KR7118000009

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sector Pharmaceuticals Wholesale

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sector Pharmaceuticals Wholesale

End-of-day quote Korea S.E. Other stock markets 23:00:00 29/04/2024 BST			5-day change	1st Jan Change
520 ^KRW	+1.36%		-0.57%	+30.00%

03-20	SMEDI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01-19	THE MEDIPHARM CO.,Ltd. cancelled the acquisition of 17.19% stake in INFOMARK Co., Ltd from THE MEDIPHARM CO.,Ltd..	CI

SMeDi Co Ltd, formerly The MediPharm Co Ltd, is a Korea-based company primarily engaged in the pharmaceutical distribution business. The Company operates through five segments. The Pharmaceuticals Business segment is engaged in the distribution of pharmaceuticals including recapsules and tablets. The Medical Business segment is engaged in the distribution of medical devices and medical supplies. The Wireless Device segment is engaged in the manufacture of wearable wireless devices. The Video Content segment is engaged in the production of video products. The Investment segment is engaged in the management consulting and investment businesses.

Number of employees: 22

KRW in Million	2022	Weight	2023	Weight	Delta
Wireless Device 50.6 %	0	0.0 %	28,213	50.6 %	-
Pharmaceutical 25.1 %	16,171	84.7 %	13,980	25.1 %	-13.55%
Video Content 9.6 %	-	-	5,351	9.6 %	-
Investments & Others 8.8 %	0	0.0 %	4,929	8.8 %	-
Medical 5.9 %	2,927	15.3 %	3,276	5.9 %	+11.94%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	19,098	100.0 %	55,750	100.0 %	+191.91%

Managers	Title	Age	Since
Beom-Yong Shin CEO	Chief Executive Officer	52	-
Min-Seo Kim DFI	Director of Finance/CFO	47	-
Dae-Woo Song SAM	Sales & Marketing	48	-
Kyung-Ho Lee AUD	Comptroller/Controller/Auditor	52	-

Members of the board	Title	Age	Since
Jeong-Mi Lee BRD	Director/Board Member	48	-
Yoon-Cheol Kim BRD	Director/Board Member	53	-
Beom-Yong Shin CEO	Chief Executive Officer	52	-
Jung-In Jang BRD	Director/Board Member	61	-
Soo-Hyun Kang BRD	Director/Board Member	51	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	10,064,610	0	0	59.09 %
Stock B	0	11,111,112	0	0
Stock C	1	142,777,363	84,364,245 ( 59.09 %)	2,154 ( 0.001509 %)

Name	Equities	%	Valuation
CHOROKBAEM MEDIA CO., LTD. 32.33 %	46,154,281	32.33 %	19 M ₩
VIDENTE CO., LTD. 7.049 %	10,064,610	7.049 %	4 M ₩
Hye-won Shin 0.4187 %	597,837	0.4187 %	245 131 ₩
Young-Jin Jung 0.2791 %	398,558	0.2791 %	163 421 ₩
Value Add Partners Co., Ltd. 0.2396 %	342,025	0.2396 %	140 241 ₩
Won-Gon Lee 0.1396 %	199,279	0.1396 %	81 710 ₩
Home Choice Corp. 0.1396 %	199,279	0.1396 %	81 710 ₩
Ji Yong Hong 0.1396 %	199,279	0.1396 %	81 710 ₩
Ji Wan Hong 0.1396 %	199,279	0.1396 %	81 710 ₩
SMEDI CO., LTD. 0.001509 %	2,154	0.001509 %	883 ₩

Name	Equities	%	Valuation
CT PROPERTY CO., LTD. 11.49%	17,323,002	11.49%	6,227,966 $
HUMAN TECHNOLOGY CO., LTD 4.04%	868,711	4.04%	3,213,501 $
SMEDI CO., LTD. 0.00%	2,154	0.00%	883 $

SMEDI Co., Ltd.

156 Byeongjeomjungang-ro

18404, Hwaseong-si

http://www.chorokbaemhc.com

	1st Jan change	Capi.
SMEDI CO., LTD.	+30.00%	53.64M
MCKESSON CORPORATION	+16.03%	70.59B
CARDINAL HEALTH, INC.	+2.22%	25.06B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.11%	8.2B
SINOPHARM GROUP CO. LTD.	-2.98%	7.92B
HUADONG MEDICINE CO., LTD	-20.55%	7.96B
H. LUNDBECK A/S	+3.11%	4.71B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.32B
EBOS GROUP LIMITED	-1.24%	4.01B
GALENICA AG	-3.44%	3.82B

Pharmaceuticals Wholesale

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Pharmaceuticals Wholesale